Portal hypertension in cirrhosis results from progressive fibrotic remodeling of the liver, which increases the resistance to hepatic sinusoidal blood flow. Increased portal venous pressure causes esophageal and gastric varices, which contribute substantially to cirrhosisrelated morbidity and mortality. The gold standard in the diagnosis of varices esophagogastroduodenoscopy (EGD) but identification of non -invasive predictors of oesophageal varices (OVs) will allow upper gastrointestinal (GIT) endoscopy to be carried out only in selected group of patients . Different non-invasive parameters including clinical, laboratory and sonographic predictors were suggested an alternative approach to perform selective screening endoscopy only in patients at high risk.
INTRODUCTION:
Liver Cirrhosis is a diffuse process characterized by tissue fibrosis and the conversion of normal liver architecture into structurally abnormal nodules and endothelial fenestrations are lost, a process termed sinusoidal capillarization (1). Portal hypertension is a clinical syndrome defined by a Portal venous pressure gradient exceeding 5 mmHg. Cirrhosis is the most common cause of portal hypertension in the Western world (2).
Portal hypertension results in the development of esophagogastric varices which often bleed; and pla ys a role in the development of ascites, hepatorenal syndrome and hepatic encephalopathy. Portal hypertension and resulting portosystemic collaterals may also be responsible for the cardiopulmonary complications like porto-pulmonary hypertension and hepatopulmonary syndrome (3).
Identification of non -invasive predictors of OVs will allow upper gastrointestinal tract(GIT) endoscopy to be carried out only in selected group of patients thus avoid un-necessary intervention and at the same time not to miss patients at risk of bleeding (4). To date, several predictive markers for presence of varices in-patient with liver cirrhosis include clinical, laboratory, and echographic data have been published. In our study, we validated the Sabadell NIHCED (noninvasive hepatitis C related cirrhosis early detection) index, it includes several demographic, laboratory and echographic parameters, also we validated the right lobe diameter to albumin ratio. 
Methods of the study:
Each patient included in the study was subjected to: § Complete history taking and physical examination. § Laboratory investigations: Aspartate aminotransferase (AST), Alanine aminotransferase (ALT), serum alkaline phosphatase, serum albumin, prothrombin time and concentration, total & differential bilirubin, hepatitis markers for HBV and HCV, blood sugar, Haemoglobin level (Hb) and serum creatinine. § Assessment of the severity of liver diseases using the Child-Pugh score (5):
Three laboratory tests (bilirubin, albumin, and prothrombin time), combined with the presence and severity of encephalopathy and ascites, are included in the ChildPugh score. The Child-Pugh score is given by the sum of the score (1 to 3) of each of the five parameters. A score of 6 or lower defines the patient as class A، 7 to 9 as class B, and 10 or higher as class C. § Abdominal ultrasonography.
-To evaluate liver (size, echogenicity and any focal lesion), portal vein, spleen, portosystemic collaterals, and detect ascites. 
Statistical analysis
Quantitative data was represented as mean, standard deviation, median and range. Data was analyzed using student t-test to compare means of two groups. When the data was not normally, distributed Mann-Whitney test was used to compare two groups. Qualitative data was presented as number and percentage and compared using either Chi square test or fisher exact test. Graphs were produced by using Excel or STATA program. Multivariate logistic regression analyses were used to determine factors predict mortality in-patient with VAH. Data were analyzed by sensitivity, specificity, positive, and negative predictive value derived from the receiver operating characteristic (ROC) curve. The diagnostic accuracy of different prognostic scores was expressed as the area under the ROC curve (AUC). Statistical analysis was performed using Medcalc for Windows (version 11.0) and STATA (version 9.2). P value was considered significant if it was less than 0.05.
Results
Among the 75 patients included in this study, 47 patients had esophageal varices (63%).
All 75 patients were categorized into two groups according to findings in oesophagogastroduodenoscopy (EGD): Group (A) 28 patients without esophageal varices (37%), Group (B) 47patients with esophageal varices (63 %). As regard sonographic data , splenomegaly, caudate lobe hypertrophy, Right hepatic lobe atrophy, collaterals and dilated splenic vein were significantely more frequent in patients with oesophageal varices (p=0.01, P=0.003, P=<0.0001, P=0.02, P=0.04) as shown in table (2) . 
Figure (2) Comparison between patients without and with varices as regards serum albumin

Analysis of NIHCED score as a predictor of esophageal varices in cirrhotic patients
All 75 patients were segregated into two groups those with esophageal varices and those without OVS. Table ( 3) summarizes the labratory and echgraphic data included in the NIHCED score. Roc curve analysis was applied to both goups with acut off score of >45.It had a sensitivity of 70%, specifity of 78%, and diagnostic accurancy of 74% with an AUC of 0.77 (95% CI, 0.66-0.86) ( 
Right lobe diameter to albumin ratio as predictorof esophageal varices.
There was a significant association between right lobe diameter toalbumin ratio and presence of varices, Patients with no varices had a mean ratio of (3.16±1.17), whereas Patients with varices had a mean ratio of (3.90±1.37) (P value =0.02) Roc curve analysis was applied to both groups with acut off score of >2.8. It had a sensitivity of 80% , specifity of 53%, and diagnostic accurancy of 67% with an AUC of 0.67(95% CI, 0.55-0.77) as shown in (table 5, figure 4 ) In this study, we evaluated the role of NIHCED score and right lobe diameter to albumin ratio in predicting the presence and grade of esophageal varices in cirrhotic patients admitted to our hospital with no history of previous gastrointestinal bleeding. We found that a decrease in platelet count and serum albumin level were significantly associated with the presence of esophageal varices in cirrhotic patients (P=0.001, P=0.007). The Pathogenesis of thrombocytopenia includes productive, consumptive or distributional mechanisms. It is commonly believed to be due to pooling and destruction of platelets in the spleen, which may be mediated by platelet-associated IgG. Reduced levels of thrombopoeitin either due to impaired production or rapid degradation may also add to thrombocytopenia. The pathogenesis of low albumin level in patients with esophageal varices is that synthesis is decreased because of the loss of hepatic cell mass. Also, portal blood flow is often decreased and poorly distributed, leading to maldistribution of nutrients and oxygen. The flow of substrate may affect certain functions of the liver, including protein synthesis We found that splenomegaly was significantly associated with the presence of esophageal varices in cirrhotic patients. The pathogenesis of splenomegaly in patients with OVS is that splenomegaly is not only caused by portal congestion, but it is mainly due to tissue hyperplasia and fibrosis. The increase in spleen size is followed by an increase in splenic blood flow, which participates in portal hypertension discriminate between cirrhotic and non-cirrhotic chronic hepatitis C patients. They reported that at a cut off >22, this index has a sensitivity of 80%, specificity of 96% and diagnostic accuracy of 94%. We have demonstrated the ability of the NIHCED score to distinguish between advanced fibrosis and absence of fibrosis or portal expansion (cut off score>45 ).We found a sensitivity of 70.2%, specificity of 78.6%, PPV of 84.6%, NPV of 61.1%, and diagnostic accuracy of 74.4% with an AUC of 0.77(95% CI: 0.66-0.86).
Bejarano et al. (8)
reported the ability of the NIHCED score to distinguish between advanced fibrosis and absence of fibrosis or portal expansion (cut off score > 6) has a sensitivity of 72%, specificity of 76.3%, PPV of 81%, NPV of 63.7%, and diagnostic accuracy of 72.5%. Vergara et al. (18) tested the ability of NIHCED score to predict the development of liver cirrhosis in patients with chronic hepatitis C during follow up (4-10years). They reported that the AUC for development of cirrhosis during follow up was 0.79. In conclusion, the NIHCED score is as effective as other non-invasive indices for determining the presence of varices. The addition of echographic data introduces prognostic factors into the information obtained NIHCED score is simple and easy to apply in any outpatient clinics. Future studies are needed to evaluate the utility of these non-invasive methods for the long-term follow-up of patients with liver cirrhosis
